Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry.
Ruscitti P, Sota J, Vitale A, Lopalco G, Iannone F, Morrone M, Giardini HAM, D'Agostin MA, Antonelli IPB, Almaghlouth I, Asfina KN, Khalil N, Sfikakis PP, Laskari K, Tektonidou M, Ciccia F, Iacono D, Riccio F, Ragab G, Hussein MA, Govoni M, Ruffilli F, Direskeneli H, Alibaz-Oner F, Giacomelli R, Navarini L, Bartoloni E, Riccucci I, Martín-Nares E, Torres-Ruiz J, Cipriani P, Di Cola I, Hernández-Rodríguez J, Gómez-Caverzaschi V, Dagna L, Tomelleri A, Makowska J, Brzezinska O, Iagnocco A, Bellis E, Caggiano V, Gaggiano C, Tarsia M, Mormile I, Emmi G, Sfriso P, Monti S, Erten Ş, Del Giudice E, Lubrano R, Conti G, Olivieri AN, Lo Gullo A, Tharwat S, Karamanakos A, Gidaro A, Maggio MC, La Torre F, Cardinale F, Ogunjimi B, Maier A, Sebastiani GD, Opris-Belinski D, Frassi M, Viapiana O, Bizzi E, Carubbi F, Fotis L, Tufan A, Kardas RC, Więsik-Szewczyk E, Jahnz-Różyk K, Fabiani C, Frediani B, Balistreri A, Rigante D, Cantarini L. Ruscitti P, et al. Among authors: direskeneli h. Semin Arthritis Rheum. 2023 Oct;62:152244. doi: 10.1016/j.semarthrit.2023.152244. Epub 2023 Jul 21. Semin Arthritis Rheum. 2023. PMID: 37517110 Free article.
Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's Disease.
Vitale A, Caggiano V, Sfikakis PP, Dagna L, Lopalco G, Ragab G, La Torre F, Almaghlouth IA, Maggio MC, Sota J, Tufan A, Hinojosa-Azaola A, Iannone F, Loconte R, Laskari K, Direskeneli H, Ruscitti P, Morrone M, Mayrink Giardini HA, Panagiotopoulos A, Di Cola I, Martín-Nares E, Monti S, De Stefano L, Kardas RC, Duran R, Campochiaro C, Tomelleri A, Alabdulkareem AM, Gaggiano C, Tarsia M, Bartoloni E, Romeo M, Hussein MA, Laymouna AH, Parente de Brito Antonelli I, Dagostin MA, Fotis L, Bindoli S, Navarini L, Alibaz-Oner F, Sevik G, Frassi M, Ciccia F, Iacono D, Crisafulli F, Portincasa P, Jaber N, Kawakami-Campos PA, Wiesik-Szewczyk E, Iagnocco A, Simonini G, Sfriso P, Balistreri A, Giacomelli R, Conti G, Frediani B, Fabiani C, Cantarini L. Vitale A, et al. Among authors: direskeneli h. Front Med (Lausanne). 2023 Dec 12;10:1256243. doi: 10.3389/fmed.2023.1256243. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38148914 Free PMC article.
RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy.
Ergenç İ, Kani HT, Karabacak M, Cömert Özer E, Mehdiyev S, Jafarov F, Abacar KY, Kutluğ Ağaçkıran S, Sevik G, Aslan R, Alibaz Öner F, İnanç N, Atagündüz MP, Seçkin D, Özen Alahdab Y, Ergun T, Direskeneli H, Atuğ Ö. Ergenç İ, et al. Among authors: direskeneli h. Turk J Gastroenterol. 2023 Mar;34(3):310. doi: 10.5152/tjg.2023.237002. Turk J Gastroenterol. 2023. PMID: 36919837 Free PMC article. No abstract available.
Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS).
Bilgin E, Demirci Yıldırım T, Özdemir Ulusoy B, Öğüt TS, Karabacak M, Sadioğlu Çağdaş Ö, Yıldırım R, Güven DC, Akleylek C, Ediboğlu E, Kutu ME, Özgür D, Kardaş RC, Bölek EÇ, Sandal Uzun G, Özsoy Z, Sarıyıldız E, Ayan G, Armağan B, Erden A, Kılıç L, Erbasan F, Alibaz-Öner F, Aşıcıoğlu E, Yazıcı A, Bilge NŞ, Küçük H, Çelik S, Bes C, Akar S, Yılmaz N, Kaşifoglu T, Cefle A, Direskeneli H, Yazısız V, Dizdar Ö, Omma A, Önen F, Karadağ Ö. Bilgin E, et al. Among authors: direskeneli h. Intern Emerg Med. 2024 Mar 29. doi: 10.1007/s11739-024-03577-9. Online ahead of print. Intern Emerg Med. 2024. PMID: 38553624
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.
Ørnbjerg LM, Rugbjerg K, Georgiadis S, Rasmussen SH, Lindström U, Pavelka K, Yilmaz N, Favalli EG, Nissen MJ, Michelsen B, Vieira-Sousa E, Jones GT, Ionescu R, Relas H, Sanchez-Piedra C, Tomšič M, Geirsson AJ, van der Horst-Bruinsma I, Askling J, Loft AG, Nekvindova L, Direskeneli H, Iannone F, Ciurea A, Fagerli KM, Santos MJ, Macfarlane GJ, Codreanu C, Eklund K, Pombo-Suarez M, Rotar Z, Gudbjornsson B, Rusman T, Østergaard M, Hetland ML. Ørnbjerg LM, et al. Among authors: direskeneli h. J Rheumatol. 2023 Aug;50(8):1009-1019. doi: 10.3899/jrheum.220459. Epub 2022 Dec 1. J Rheumatol. 2023. PMID: 36455943
A cross-sectional study on activity impairment in primary Sjogren's syndrome.
Yenissoy Y, Altıngöz EN, Kapusuz A, Abacar K, Tatlı I, Türe-Özdemir F, Karacaylı U, Yay M, Direskeneli H, Fortune F, Inanc N, Mumcu G. Yenissoy Y, et al. Among authors: direskeneli h. Oral Dis. 2023 May 29. doi: 10.1111/odi.14620. Online ahead of print. Oral Dis. 2023. PMID: 37246927
Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis.
Kaymaz-Tahra S, Bayindir O, Ince B, Ozdemir İsik O, Kutu ME, Karakas O, Yildirim TD, Ademoglu Z, Ediboglu ED, Uludogan BCE, Ilgin C, Bilge NSY, Kasifoglu T, Akar S, Emmungil H, Onen F, Omma A, Kanitez NA, Yazici A, Cefle A, Inanc M, Aksu K, Keser G, Direskeneli H, Alibaz-Oner F. Kaymaz-Tahra S, et al. Among authors: direskeneli h. Semin Arthritis Rheum. 2024 Jun;66:152446. doi: 10.1016/j.semarthrit.2024.152446. Epub 2024 Apr 8. Semin Arthritis Rheum. 2024. PMID: 38669786
Factors Associated with 28-day Critical Illness Development During the First Wave of COVID-19.
Sili U, Ay P, Bilgin H, Topuzoğlu A, Tükenmez-Tigen E, Ertürk-Şengel B, Yağçı-Çağlayık D, Balcan B, Kocakaya D, Olgun-Yıldızeli Ş, Gül F, Bilgili B, Can-Sarınoğlu R, Karahasan-Yağcı A, Mülazimoğlu-Durmuşoğlu L, Eryüksel E, Odabaşı Z, Direskeneli H, Karakurt S, Korten V. Sili U, et al. Among authors: direskeneli h. Infect Dis Clin Microbiol. 2023 Jun 23;5(2):94-105. doi: 10.36519/idcm.2023.206. eCollection 2023 Jun. Infect Dis Clin Microbiol. 2023. PMID: 38633015 Free PMC article.
373 results